The Impact of Microbial Invasion on Host Tissue Integrity in Chronic Wounds

Althea Ravenshade^*
*Correspondence: Althea Ravenshade, Department of Microbial Pathology, University of New Haven Medical Campus, New Haven, Connecticut, USA, Email:

Introduction

Chronic wounds, which include ulcers, diabetic foot wounds, pressure sores, and venous stasis ulcers, pose a significant global health burden. These types of wounds remain unhealed for extended periods, often due to various factors such as poor blood circulation, compromised immune function, and ongoing microbial invasion. The involvement of pathogens in chronic wound infections is a major contributor to the persistent inflammation, delayed healing, and tissue damage characteristic of these wounds. Understanding the interaction between microorganisms and host tissue is crucial for developing more effective treatments for chronic wounds. Microbial invasion in chronic wounds exacerbates the wound environment by altering the immune response, promoting inflammation, and hindering the body's natural healing process. The biofilm formation of bacteria, the ability of pathogens to evade the immune system, and the production of harmful toxins contribute significantly to tissue destruction. This article explores the mechanisms by which microbial invasion impacts host tissue integrity in chronic wounds, focusing on the role of bacteria, fungi, and other microorganisms in exacerbating the pathological processes that impair healing [1].

Description

The pathophysiology of chronic wounds

Chronic wounds are typically defined as those that fail to progress through the normal stages of healing within a reasonable time frame, often over several weeks or months. The stages of wound healing, including hemostasis, inflammation, proliferation, and remodeling, can be disrupted by a range of factors. When microbial pathogens invade the wound site, they can prevent the transition from inflammation to the proliferative phase, leading to prolonged inflammation, tissue destruction, and impaired tissue regeneration. The wound bed in chronic wounds often becomes a suitable environment for microbial colonization due to factors like inadequate blood flow, hypoxia, and the accumulation of necrotic tissue. This creates a breeding ground for both aerobic and anaerobic bacteria, fungi, and other microorganisms. The presence of microbes in the wound leads to the production of virulence factors such as enzymes, toxins, and biofilm formation, all of which disrupt normal tissue function and compromise the integrity of the tissue [2].

Microbial species involved in chronic wounds

Several microbial species have been identified as common pathogens in chronic wounds. Among the most prevalent bacteria are Staphylococcus aureus, Pseudomonas aeruginosa, and Streptococcus species. These pathogens are capable of forming biofilms, which are complex communities of microorganisms encased in a protective extracellular matrix. Biofilms play a crucial role in chronic wound infections, as they provide a defense mechanism against both the host immune system and antimicrobial treatments.

Staphylococcus aureus: A major pathogen in chronic wounds, S. aureus is known for its ability to form biofilms and its resistance to many antibiotics. This bacterium produces a range of virulence factors, including proteases and toxins, that degrade host tissues and modulate the immune response to enhance its survival in the wound site.

Pseudomonas aeruginosa: This opportunistic pathogen is frequently involved in chronic wounds, particularly in diabetic foot ulcers and burn wounds. P. aeruginosa produces exotoxins, such as elastase, that degrade collagen and elastin, further impairing tissue healing. Its ability to form biofilms also enhances its persistence in the wound.

Streptococcus species: Streptococci are often implicated in both acute and chronic wound infections. They can cause severe tissue damage by secreting exoenzymes like hyaluronidase, which breaks down extracellular matrix components, facilitating the spread of infection.

In addition to these bacteria, fungal pathogens such as Candida albicans and Aspergillus species have been increasingly recognized in chronic wounds, particularly in immunocompromised patients. Fungal infections can lead to further complications, including necrosis and impaired tissue regeneration [3].

The role of biofilms in chronic wounds

Biofilm formation is a hallmark of chronic wound infections and significantly contributes to tissue damage. Biofilms consist of microbial cells encased in a self-produced matrix of Extracellular Polymeric Substances (EPS), which protect the microbes from both immune cells and antibiotics. In chronic wounds, biofilm-associated microorganisms are often more resistant to host immune responses and treatment strategies, leading to persistent infection and ongoing tissue damage. Within the biofilm, bacteria can exchange genetic material, facilitating the spread of antibiotic resistance genes. This makes the treatment of chronic wound infections more challenging. The matrix of biofilms also promotes the formation of channels that allow for the exchange of nutrients and waste products, enabling the microorganisms to thrive in a hostile environment. The presence of biofilms in chronic wounds leads to a cycle of continuous tissue damage. Biofilm-associated bacteria secrete proteases, lipases, and other enzymes that degrade the extracellular matrix, causing breakdown of collagen, elastin, and other vital components of the tissue structure. This results in the loss of tissue integrity, delayed healing, and increased inflammation [4].

Immune system disruption and chronic inflammation

The immune response to microbial invasion in chronic wounds is often dysregulated. Normally, when pathogens invade tissue, the immune system initiates a series of inflammatory responses to combat the infection. However, in chronic wounds, the persistent presence of microorganisms leads to prolonged inflammation. This is partly due to the continuous release of proinflammatory cytokines, which promote the recruitment of immune cells to the site of infection. While the immune response is intended to clear the infection, the sustained presence of bacteria and their virulence factors creates a vicious cycle of inflammation. Neutrophils and macrophages, essential players in the immune response, may become dysfunctional in chronic wounds. Instead of clearing the infection, they release proteolytic enzymes that break down host tissues, contributing to the destruction of the wound bed and surrounding tissue. Furthermore, chronic inflammation impairs the normal wound healing process. The inflammatory phase, which is crucial for defense against pathogens and tissue repair, becomes prolonged, and the transition to the proliferative phase of healing is delayed. This results in the failure of tissue regeneration and prolonged wound closure times [5].

Conclusion

The impact of microbial invasion on host tissue integrity in chronic wounds is profound, contributing to delayed healing, ongoing tissue damage, and impaired wound closure. Pathogens such as Staphylococcus aureus, Pseudomonas aeruginosa, and various fungi establish biofilms, secrete harmful toxins, and disrupt the immune response, creating an environment where tissue regeneration is hindered, and inflammation persists. A better understanding of the molecular and microbial factors that contribute to chronic wound pathology is crucial for developing more effective therapies. Addressing biofilm formation, controlling microbial virulence, and enhancing immune function are essential strategies in treating chronic wounds. By targeting these microbial and host interactions, it may be possible to improve wound healing outcomes and reduce the burden of chronic wound infections on healthcare systems. Ultimately, the integration of microbiological and pathological research into clinical practice will provide new avenues for treating chronic wounds, offering hope for patients suffering from these often debilitating conditions.

Acknowledgment

None.

Conflict of Interest

None.

References

1. Uberoi, Aayushi, Amelia McCready-Vangi and Elizabeth A. Grice. "The wound microbiota: Microbial mechanisms of impaired wound healing and infection." Nat Rev Microbiol (2024): 1-15.

Google Scholar, Crossref, Indexed at

2. Pastar, Irena, Nathan C. Balukoff, Jelena Marjanovic and Vivien Y. Chen, et al. "Molecular pathophysiology of chronic wounds: Current state and future directions." Cold Spring Harb Perspect Biol 15 (2023): a041243.

Google Scholar, Crossref, Indexed at

3. Puca, Valentina, Roberta Zita Marulli, Rossella Grande and Irene Vitale, et al. "Microbial species isolated from infected wounds and antimicrobial resistance analysis: Data emerging from a three-years retrospective study." Antibiotics 10 (2021): 1162.

Google Scholar, Crossref, Indexed at

4. Diban, Firas, Silvia Di Lodovico, Paola Di Fermo and Simonetta D’Ercole, et al. "Biofilms in chronic wound infections: Innovative antimicrobial approaches using the in vitro Lubbock chronic wound biofilm model." Int J Mol Sci 24 (2023): 1004.

Google Scholar, Crossref, Indexed at

5. Ellis, Samantha, Elaine J. Lin and Danielle Tartar. "Immunology of wound healing." Curr Dermatol Rep 7 (2018): 350-358.

Google Scholar, Crossref, Indexed at